What follows is a partial list of alternative names that have been either used or proposed (with approximate dates):
Factitious Disorder Imposed on Another (current) (U.S., 2013)  American Psychiatric Association, DSM-5
Factitious Disorder by Proxy (FDP, FDbP) (proposed) (U.S., 2000)  American Psychiatric Association, DSM-IV-TR
Fictitious Disorder by Proxy (FDP, FDbP) (proposed) (U.S., 1994)  American Psychiatric Association, DSM-IV
Fabricated or Induced Illness by Carers (FII) (U.K., 2002)  The Royal College of Pediatrics and Child Health
Factitious Illness by Proxy (1996)  World Health Organization
Pediatric Condition Falsification (PCF) (proposed) (U.S., 2002)  American Professional Society on the Abuse of Children proposed this term to diagnose the victim (child); the perpetrator (caregiver) would be diagnosed "factitious disorder by proxy"; MSbP would be retained as the name applied to the disorder that contains these two elements, a diagnosis in the child and a diagnosis in the caretaker. Induced Illness (Munchausen Syndrome by Proxy) (Ireland, 1999–2002)  Department of Health and Children
Munchausen Syndrome by Proxy (2002) Professor Roy Meadow. Meadows Syndrome (1984–1987) named after Roy Meadow. This label, however, had already been in use since 1957 to describe a completely unrelated and rare form of cardiomyopathy. Polle Syndrome (1977–1984)  coined by Burman and Stevens, from the then-common belief that Baron Münchhausens second wife gave birth to a daughter named Polle during their marriage. The baron declared that the baby was not his, and the child died from "seizures" at the age of 10 months.
"Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation". Anesthesiology. 66 (6): 766–73. doi:10.1097/00000542-198706000-00010. PMC 2965586. PMID 3296855. External links
"Aminocaproic acid". Drug Information Portal. U.S. National Library of Medicine.